Modulation of nerve growth factor and choline acetyltransferase expression in rat hippocampus after chronic exposure to haloperidol, risperidone, and olanzapine

Psychopharmacology

Volumn 172, Issue 4, 2004, Pages 365-374

  Parikh, Vinay ^a,b   Terry, Alvin V ^c   Khan, Mohammad M ^a   Mahadik, Sahebarao P ^a,b  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b Specialty Care Service Line Veterans   (United States)

^c UNIVERSITY OF GEORGIA   (United States)

Author keywords

Antipsychotics; Choline acetyltransferase; Cognition; Haloperidol; Nerve growth factor; Olanzapine; Rat; Risperidone; Schizophrenia

Indexed keywords

BRAIN PROTEIN; CHOLINE ACETYLTRANSFERASE; DRINKING WATER; HALOPERIDOL; NERVE GROWTH FACTOR; NEUROLEPTIC AGENT; OLANZAPINE; RISPERIDONE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHOLINERGIC ACTIVITY; CHOLINERGIC NERVE CELL; CHRONIC DRUG ADMINISTRATION; COGNITION; CONTROLLED STUDY; DENTATE GYRUS; DRUG BLOOD LEVEL; DRUG EFFECT; ELECTROENCEPHALOGRAM; ENZYME LINKED IMMUNOSORBENT ASSAY; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LONG TERM EXPOSURE; MALE; NERVE PROJECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RAT; SCHIZOPHRENIA;

ADMINISTRATION, ORAL; ANIMALS; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; CHOLINE O-ACETYLTRANSFERASE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME-LINKED IMMUNOSORBENT ASSAY; HALOPERIDOL; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; MALE; NERVE GROWTH FACTOR; RATS; RATS, WISTAR; RISPERIDONE; SEPTUM OF BRAIN;

EID: 1642573944     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-003-1669-6     Document Type: Article

References (52)

1. Alberch J, Carman-Krzan M, Fabrazzo M, Wise BC (1991) Chronic treatment with scopolamine and physostigmine changes nerve growth factor (NGF) receptor density and NGF content in rat brain. Brain Res 542:233-240
2. Alleva E, Della Seta D, Cirulli F, Aloe L (1996) Haloperidol treatment decreases nerve growth factor levels in the hypothalamus of adult mice. Prog Psychopharmacol Biol Psychiatry 20:483-489
3. Aloe L, Iannitelli A, Bersani G, Alleva E, Angelucci F, Maselli P, Manni L (1997) Haloperidol administration in humans lowers plasma nerve growth factor level: evidence that sedation induced opposite effects to arousal. Neuropsychobiology 36:65-68
4. Amaral DG, Kurz J (1985) An analysis of the origins of the cholinergic and noncholinergic septal projections to the hippocampal formation of the rat. J Comp Neurol 240:37-59
5. Andersson C, Hamer RM, Lawler CP, Mailman RB, Lieberman JA (2002) Striatal volume changes in the rat following long-term administration of typical and atypical antipsychotic drugs. Neuropsychopharmacology 27:143-151
6. Angelucci F, Aloe L, Gruber SHM, Fiore M, Mathe AK (2000) Chronic antipsychotics treatment selectively alters nerve growth factor and neuropeptide Y immunoreactivity and the distribution of choline acetyltransferase in rat brain regions. Int J Neuropsychopharmacol 3:13-25
7. Baxter MG, Frick KM, Price DL, Breckler SJ, Markowska AL, Gorman LK (1999) Pre-synaptic markers of cholinergic function in the rat brain: relationship with age and cognitive status. Neuroscience 89:771-779
8. Bersani G, Iannitelli A, Maselli P, Pancheri P, Aloe L, Angelucci F, Alleva E (1999) Low nerve growth factor plasma levels in schizophrenic patients: a preliminary study. Schizophr Res 37:197-203
9. Buckley PF (2001) Broad therapeutic uses of atypical antipsychotic medications. Biol Psychiatry 50:912-924
10. 1-adrenergic and muscarinic receptors in vivo in rats. Psychopharmacology 124:87-94
11. Cuesta MJ, Peralta V, Zarzuela A (2001) Effects of olanzapine and other antipsychotics on cognitive function in chronic schizophrenia: a longitudinal study. Schizophr Res 48:17-28
12. Gallagher M, Nicolle MM (1993) Animal models of normal aging: relationship between cognitive decline and markers of hippocampal circuitary. Behav Brain Res 57:155-162
13. Garofalo L, Ribeiro-da-Silva A, Cuello AC (1992) Nerve growth factor-induced synaptogenesis and hypertrophy of cortical cholinergic terminals. Proc Natl Acad Sci USA 89:2639-2643
14. Green MF, Braff DL (2001) Translating the basic and clinical cognitive neuroscience of schizophrenia to drug development and clinical trials of antipsychotic medications. Biol Psychiatry 49:374-384
15. Harder JA, Baker JF, Ridley RM (1998) The role of the central cholinergic projections in cognition: implications of the effects of scopolamine on discrimination learn by monkeys. Brain Res Bull 45:319-326
16. Hefti F (1994) Neurotrophic factor therapy for nervous system degenerative diseases. J Neurobiol 25:1418-1435
17. Ichikawa J, Dai J, O'laughlin IA, Fowler WL, Meltzer HY (2002) Atypical, but not typical, antipsychotics drugs increase cortical acetylcholine release without an effect in the nucleus accumbens or striatum. Neuropsychopharmacology 26:325-339
18. Jeste DV, Lohr JB, Manley M (1992) Study of neuropathologic changes in the striatum following 4, 8 and 12 months of treatment with fluphenazine in rats. Psychopharmacology 106:154-160
19. 2 receptor occupancy of clozapine, risperidone and olanzapine in schizophrenia. Am J Psychiatry 156:286-293
20. Kinon BJ, Lieberman JA (1996) Mechanisms of action of atypical antipsychotics drugs: a critical analysis. Psychopharmacology 124:2-34
21. Korsching S, Auburger G, Heumann R, Scott J, Thoenen H (1985) Levels of nerve growth factor and its mRNA in the central nervous system of the rat correlate with cholinergic enervation. EMBO J 4:1389-1393
22. Kromer LF (1987) Nerve growth factor treatment after brain injury prevents neuronal death. Science 235:214-216
23. Lee MA, Jayathilake K, Meltzer HY (1999) A comparison of the effect of clozapine with typical neuroleptics on cognitive function in neuroleptic-responsive schizophrenia. Schizophr Res 37:1-11
24. Lee T-H, Kato H, Pan L-H, Ryu JH, Kogure K, Itoyama Y (1998) Localization of nerve growth factor, TrkA and P75 immunoreactivity in the hippocampal formation and basal forebrain of adult rats. Neuroscience 83:335-349
25. Lee T-H, Kato HK, Kogure K, Itoyama Y (1996) Temporal profile of nerve growth factor-like immunoreactivity after transient focal cerebral ischemia in rats. Brain Res 713:199-210
26. Levi-Montalcini R (1987) The nerve growth factor 35 years later. Science 237:1154-1162
27. Lo DC (1995) Neurotrophic factors and synaptic plasticity. Neuron 15:979-981
28. Mahadik SP, Laev H, Korenoversusky A, Karpiak SE (1988) Haloperidol alters rat CNS cholinergic system: enzymatic and morphological analyses. Biol Psychiatry 24:199-217
29. Mahadik SP, Evans DR, Terry A, Hill WD (2001) Neuroprotective action of atypical antipsychotics in schizophrenia: improved cognitive performance and underlying mechanism of action. Schizophr Res 49:94
30. Marchisio PC, Naldini L, Calissano P (1980) Intracellular distribution of nerve growth factor in rat pheochromocytoma PC12 cells: evidence for a perinuclear and intranuclear location. Proc Natl Acad Sci USA 77:1656-1660
31. Mausset A-L, Seze R, Montpeyroux F, Privat A (2001) Effects of radiofrequency exposure on the GABAergic system in the rat cerebellum: clues from semi-quantitative immunohistochemistry. Brain Res 912:33-46
32. McKinney M, Coyle JT, Hedreen JC (1983) Topographic analysis of the innervation of the rat neocortex and hippocampus by the basal forebrain cholinergic system. J Comp Neurol 217:103-121
33. Meltzer HY (1995) Atypical antipsychotics drugs. In: Bloom FE, Kupfer DJ (eds) Psychopharmacology: fourth generation of progress. Raven Press New York, pp 1277-1286
34. Nakamura N, Fujita H, Kawata M (2002) Effects of the gonadectomy on immunoreactivity for choline acetyltransferase in the cortex, hippocampus, and basal forebrain of adult male rats. Neuroscience 109:473-485
35. Nilsson OG, Gage FH (1993) Anticholinergic sensitivity in the aging rat septohippocampal system as assessed in a spatial memory task. Neurobiol Aging 14:487-497
36. Parikh V, Khan MM, Salat P, Kalla A, Mahadik SP (2003a) Effects of risperidone, olanzapine and clozapine versus. haloperidol on nerve growth factor and cholinergic activity in rat brain. Biol Psychiatry 53:26S
37. Parikh V, Evans DR, Khan MM, Mahadik SP (2003b) Nerve growth factor levels in never medicated first episode psychotic patients and medicated chronic schizophrenic patients. Schizophr Res 60:117-123
38. Paxinos G, Watson CR (1998) The rat atlas in stereotaxic coordinates, 4th edn. Academic Press, San Diego, Calif.
39. Powchik P, Davidson M, Haroutunian V, Gabriel SM, Purohit DP, Perl DP, Harvey PD, Davis KL (1998) Postmortem studies in schizophrenia. Schizophr Bull 24:325-341
40. Rossner S, Wortwein G, Gu Z, Yu J, Schliebs R, Bigl V, Perez-Polo JR (1997) Cholinergic control of nerve growth factor in adult rats: evidence from cortical cholinergic deafferentation and chronic drug treatment. J Neurochem 69:947-953
41. Rylett RJ, Williams LR (1994) Role of neurotrophins in cholinergic-neuron function in the adult and aged CNS. Trends Neurosci 17:486-490
42. Seeman P (2002) Atypical antipsychotics: mechanism of action. Can J Psychiatry 47:27-38
43. Sharma T, Modeler D (1998) The cognitive efficacy of atypical antipsychotics in schizophrenia. J Clin Psychopharmacol 18:12S-19S
44. Shirazi-Southall S, Rodriguez DE, Nomikos GG (2002) Effects of typical and atypical antipsychotics and receptor selective compounds on acetylcholine efflux in the hippocampus of the rat. Neuropsychopharmacology 26:583-594
45. Spohn HE, Strauss ME (1989) Relation of neuroleptic and anticholinergic medication to cognitive functions in schizophrenia. J Abnorm Psychol 98:367-380
46. Terry AV, Hill WD, Parikh V, Evans DR, Waller JL, Mahadik SP (2002) Differential effects of chronic haloperidol and olanzapine exposure on brain cholinergic markers and spatial learning in rats. Psychopharmacology 164:360-368
47. Terry AV, Hill WD, Parikh V, Waller JL, Evans DR, Mahadik SP (2003) Differential effects of haloperidol, risperidone and clozapine exposure on cholinergic markers and spatial learning performance in rats. Neuropsychopharmacology 28:300-309
48. Thoenen H (1995) Neurotrophins and neuronal plasticity. Science 270:593-598
49. Thoenen H, Bandtlow C, Heumann R (1987) The physiological function of nerve growth factor in the central nervous system: comparison with the periphery. Rev Physiol Biochem Pharmacol 109:145-178
50. Tollefson GD (1996) Cognitive functions in schizophrenic patients. J Clin Psychiatry 57 (Suppl II):31-39
51. Weinberger DR (1999) Cell biology of the hippocampal formation in schizophrenia. Biol Psychiatry 45:395-402
52. Woolf NJ, Eckenstein F, Butcher LL (1984) Cholinergic system in the rat brain: I. Projections to the limbic telencephalon. Brain Res Bull 13:751-784